TROG (the Trans-Tasman Radiation Oncology Group) is a global leader in cancer research and has been successfully improving the outcomes of cancer patients since 1989.
Our mission is to improve treatments and quality of life for cancer patients, and we do so by working collaboratively. We areone of the largest clinical trial groups in Australia and New Zealand and we work with hospitals, universities, cancer centres and the wider community around the world to conduct life-changing research.
TROG Cancer Research’s focus is providing hope to people with all cancer types through one treatment, radiation therapy.
Our research findings have helped advance the way many cancers are treated worldwide.